Dulaglutide U.S. label context · version 1
This page preserves this version's wording and source pins. Open the current profile →
What does the U.S. product label say?
Trulicity · Read September 15, 2026 · Preserved label summary 1
Which population and use does the label cover?
The label covers glycemic control with diet and exercise in adults and children aged ten years and older with type 2 diabetes. Its cardiovascular indication concerns adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors. Label: 1 ↗
Which safety limits matter?
The boxed warning reports thyroid C-cell tumors in rats, with uncertain human relevance. Contraindications include a personal or family history of medullary thyroid carcinoma, MEN 2 and serious hypersensitivity. Other warnings include pancreatitis, hypoglycemia with insulin or insulin secretagogues, kidney injury from volume depletion, severe gastrointestinal reactions, retinopathy complications, gallbladder disease and aspiration during anesthesia or deep sedation. Label: boxed warning, 4, 5 ↗
Label edition and source pins
U.S. product labeling hosted by the National Library of Medicine. This account concerns this product and label edition; other formulations and jurisdictions require their own records.
TRULICITY (dulaglutide) injection, solution · SPL version 62 · published 2026-08-10
Label ZIP SHA-256: 0be61134741cd12e32e7ea35d42b7ad3d11a0a333b31e08005cf499692d46779. Extracted XML SHA-256: 2a790740cae6415ba5160d0c578d599e26decb426a6f5c59d99803bb53b227d5.